Proteomics and transcriptomics with universal NGS readout

Scientists need high-throughput tools to allow them to further understand protein expression with a detailed analysis of cellular transcriptomes - whether at the bulk level or with single-cell resolution.

This guide will outline how proteomics via next-generation sequencing (NGS) can be used to study biological processes, tumor biology, biomarker discovery, and host-pathogen interactions, expanding a new era in proteogenomics.

Download the guide to explore the Power of Proteomics via NGS.

Proteomics and transcriptomics with universal NGS readout

Image Credit: Illumina, Inc

About Illumina, Inc

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Sep 7, 2023 at 10:08 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2023, September 07). Proteomics and transcriptomics with universal NGS readout. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/whitepaper/20230907/Proteomics-and-transcriptomics-with-universal-NGS-readout.aspx.

  • MLA

    Illumina, Inc.. "Proteomics and transcriptomics with universal NGS readout". News-Medical. 21 November 2024. <https://www.news-medical.net/whitepaper/20230907/Proteomics-and-transcriptomics-with-universal-NGS-readout.aspx>.

  • Chicago

    Illumina, Inc.. "Proteomics and transcriptomics with universal NGS readout". News-Medical. https://www.news-medical.net/whitepaper/20230907/Proteomics-and-transcriptomics-with-universal-NGS-readout.aspx. (accessed November 21, 2024).

  • Harvard

    Illumina, Inc.. 2023. Proteomics and transcriptomics with universal NGS readout. News-Medical, viewed 21 November 2024, https://www.news-medical.net/whitepaper/20230907/Proteomics-and-transcriptomics-with-universal-NGS-readout.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.